GlobeNewswire: Focal Therapeutics Contains the last 10 of 2 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T11:30:33ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2016/07/11/855066/10164028/en/School-of-Oncoplastic-Surgery-Schedules-September-Session.html?f=22&fvtc=4&fvtv=28539School of Oncoplastic Surgery Schedules September Session2016-07-11T15:10:34Z<![CDATA[Course Teaches Breast Surgeons to Optimize Cosmetic Outcomes While Controlling Cancer LAS VEGAS, July 11, 2016 (GLOBE NEWSWIRE) -- Breast surgery experts from across the nation will gather in Nevada this September to learn oncoplastic surgery, now the most advanced form of breast cancer surgery available. The two-and-a-half-day course to be held by the ]]>https://www.globenewswire.com/news-release/2016/04/07/826976/10161673/en/Focal-Therapeutics-Launches-BioZorb-LP-Expanding-Utility-of-3D-Implant-for-Breast-Cancer-Patients.html?f=22&fvtc=4&fvtv=28539Focal Therapeutics Launches BioZorb LP, Expanding Utility of 3D Implant for Breast Cancer Patients2016-04-07T19:40:56Z<![CDATA[More Than 200 U.S. Centers Now Offer Bioabsorbable Marker Used in Breast Conservation Therapy ALISO VIEJO, Calif., April 7, 2016 (GLOBE NEWSWIRE) -- Focal Therapeutics, makers of the three-dimensional BioZorb™ implant used in breast conservation therapy, announced it has launched BioZorb LP™. The new "low-profile" design expands the spectrum of surgical sites in which the bioabsorbable marker can be placed.]]>